Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma HONG KONG, March 6, 2025 /PRNewswire/ — Akeso, Inc. (9926. HK) ("Akeso"… CISION PRNewswireMarch 6, 2025
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line… CISION PRNewswireMarch 6, 2025
Press ReleaseFARMLORE IN BENGALURU IS UNVEILED AS THE WINNER OF THE AMERICAN EXPRESS ONE TO WATCH AWARD 2025 AS PART OF ASIA'S 50 BEST RESTAURANTS LONDON, March 6, 2025 /PRNewswire/ — Farmlore in Bengaluru has been honoured as… CISION PRNewswireMarch 6, 2025
SK keyfoundry Launches 3D Hall-effect Sensor Technology Capable of Measuring Speed and Direction SEOUL, South Korea, March 6, 2025 /PRNewswire/ — SK keyfoundry, an 8-inch… CISION PRNewswireMarch 6, 2025
Press ReleaseApollo Group TV Expands Payment Options Making Premium Streaming More Accessible with Raydium Solutions BOSTON, March 6, 2025 /PRNewswire/ — In a strategic partnership with Raydium… CISION PRNewswireMarch 6, 2025
Baidu Announces Pricing of CNY10 Billion CNY-denominated Senior Notes BEIJING, March 6, 2025 /PRNewswire/ — Baidu, Inc. (NASDAQ: BIDU and HKEX:… CISION PRNewswireMarch 6, 2025
FinTags Empowers Malaysian Accounting Firms with XBRL Solutions for MBRS 2.0 Compliance KUALA LUMPUR, Malaysia, March 6, 2025 /PRNewswire/ — FinTags Sdn Bhd, Malaysia’s… CISION PRNewswireMarch 6, 2025
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION ITASCA, Ill., March 6, 2025 /PRNewswire/ — Lakeside Holding Limited ("Lakeside" or… CISION PRNewswireMarch 6, 2025
